Acne Drugs Market Overview 2023-2032 – Key Opportunities And Strategies

The Acne Drugs Global Market Report 2023 by The Business Research Company, provides acne drugs market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Acne Drugs Market:

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

According to The Business Research Company’s Acne Drugs Global Market Report 2023, the global acne drugs market size will grow from $5.44 billion in 2022 to $5.74 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global acne drugs market size is expected to grow to $6.90 billion in 2027 at a CAGR of 4.7%.

An increase in the disposable income of people is one of the major drivers in the acne drug market. An increase in disposable income is usually due to an improved economy leading to increased wages and salaries and boosting healthcare expenditure. According to the Office For National Statistics (UK), in 2020, the average household disposable income in the UK was £30,800 ($37,830), an increase of 2.3% from 2019. The rise in disposable income and increased expenditure on facial care products is expected to continue, thereby driving the market in the forecast period.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=2412&type=sm

The acne drugs market is segmented:

1) By Type: Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs

2) By End User: Hospitals & Clinics, Pharmacies & Drug Stores, Ambulatory Surgical Centres

3) By Therapeutic Class: Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide

Combination therapy is the latest trend in the acne drug market. Combination therapy is the process of combining two drugs with different mechanisms of action, such combinations of medication have better efficacy and adherence when compared with monotherapy (the use of only a single drug by itself). The combination of a topical retinoid drug, which unclogs the pores, along with an antimicrobial drug, which is used to treat an infection is being used to treat acne drugs. Example of combination therapy includes Epiduo, Acanya, Ziana, and Benzamycin produced by Galderma, Allergan, Medicis, and Atrix respectively.

The acne drugs market report table of contents includes: